EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands

Frank H Ardesch, Rose J Geurten, Jeroen N Struijs, Dirk Ruwaard, Henk J G Bilo, Arianne M J Elissen

Primary Care Diabetes · 2025

DOI: 10.1016/j.pcd.2024.12.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Primary Care Diabetes, 2025. Verfasst von Frank H Ardesch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands. Electronic address: F.H.Arde…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Healthcare Disparities, Cardiovascular Diseases, Practice Patterns, Physicians'. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study aims to analyze prescription patterns of new diabetes medication and assess socioeconomic disparities in their initiation among individuals with T2DM with very high cardiovascular risk. METHODS: Individuals diagnosed with T2DM and very high cardiovascular risk were identified (N = 10,768) based on general practitioner's electronic health record data. SGLT-2is and GLP-1RAs prescription patterns were examined. Furthermore, the association between SES and the prescription of SGLT-2is and GLP-1RAs in 2022 was investigated. RESULTS: Despite the increase in prescription rates of SGLT-2is and GLP-1RAs between 2019 and 2022, approximately 85 % and 93 % of eligible individuals did not receive SGLT-2is and GLP-1RAs in 2022, respectively. We found a positive association between SGLT-2is prescription and SES in only the 4th quintile compared to 1st quintile (referent) in the fully adjusted model (OR 1.29 95 % CI:1.08-1.54). CONCLUSIONS: The prescription rates among eligible individuals highlight significant room for improvement in aligning prescribing practices with guidelines. We found no profound socioeconomic gradient in initiation of SGLT-2is and GLP-1RAs. The latter may be due to guidelines' clear indication of the eligible population and GP education. Future development and potential disparities in initiation and maintenance should be monitored to ensure equitable prescribing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Healthcare DisparitiesCardiovascular DiseasesPractice Patterns, Physicians'Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor AgonistsHumansMaleFemaleMiddle AgedNetherlandsAgedSocioeconomic FactorsRisk AssessmentHeart Disease Risk FactorsDrug PrescriptionsSocioeconomic Disparities in Health

Stichwörter der Autor:innen

GLP-1RAsHealth equitySGLT-2iSocioeconomic statusType 2 diabetes mellitusVery high cardiovascular risk

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands. Electronic address: F.H.Ardesch@lumc.nl.
  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: R.Geurten@…
  • Department of Public Health and Primary Care/Health Campus The Hague, Leiden University Medical Center, the Netherlands; Department of Population Health and Health Services Research, National Institute of Public Health…
  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: D.Ruwaard@…
  • Department of Internal Medicine, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands. Electronic address: H.J.G.Bilo@isala.nl.
  • Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: A.Elissen@…

Zitieren

APA

Ardesch, F. H., Geurten, R. J., Struijs, J. N., Ruwaard, D., Bilo, H. J. G., & Elissen, A. M. J. (2025). Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2024.12.011

Vancouver

Ardesch FH, Geurten RJ, Struijs JN, Ruwaard D, Bilo HJG, Elissen AMJ. Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands. Primary Care Diabetes. 2025. doi:10.1016/j.pcd.2024.12.011

BibTeX
@article{Ardesch2025,
  author = {Ardesch, Frank H and Geurten, Rose J and Struijs, Jeroen N and Ruwaard, Dirk and Bilo, Henk J G and Elissen, Arianne M J},
  title = {Investigating socioeconomic disparities in prescribing new diabetes medications in individuals with type 2 diabetes and very high cardiovascular risk in the Netherlands},
  journal = {Primary Care Diabetes},
  year = {2025},
  doi = {10.1016/j.pcd.2024.12.011}
}
Kostenlos starten →